Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Climb Bio (CLYM) Net Cash Flow (2020 - 2026)

Climb Bio filings provide 7 years of Net Cash Flow readings, the most recent being -$27.3 million for Q1 2026.

  • Quarterly Net Cash Flow rose 53.03% to -$27.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$20.7 million through Mar 2026, up 72.8% year-over-year, with the annual reading at -$51.5 million for FY2025, 769.94% down from the prior year.
  • Net Cash Flow hit -$27.3 million in Q1 2026 for Climb Bio, down from $9.9 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $118.1 million in Q2 2024 and bottomed at -$77.1 million in Q3 2024.
  • Average Net Cash Flow over 5 years is -$2.3 million, with a median of $1.7 million recorded in 2022.
  • The largest annual shift saw Net Cash Flow crashed 654.12% in 2023 before it skyrocketed 1337.58% in 2024.
  • Climb Bio's Net Cash Flow stood at $5.8 million in 2022, then soared by 519.13% to $36.1 million in 2023, then tumbled by 263.18% to -$58.9 million in 2024, then skyrocketed by 116.78% to $9.9 million in 2025, then crashed by 376.55% to -$27.3 million in 2026.
  • Per Business Quant, the three most recent readings for CLYM's Net Cash Flow are -$27.3 million (Q1 2026), $9.9 million (Q4 2025), and $3.1 million (Q3 2025).